Canine atopic dermatitis: a retrospective study of 266 cases examined at the University of California, Davis, 1992-1998. Part I. Clinical features and allergy testing results

2002 ◽  
Vol 13 (2) ◽  
pp. 89-102 ◽  
Author(s):  
Gila Zur ◽  
Peter J. Ihrke ◽  
Stephen D. White ◽  
Philip H. Kass
2018 ◽  
Vol XXIII (135) ◽  
pp. 60-72
Author(s):  
Leandro Haroutune H. Galati ◽  
Carlos Eduardo Larson Júnior ◽  
Alexandre Merlo ◽  
Carlos Eduardo Larson

Canine atopic dermatitis gains worldwide attention due to its high incidence, and to recent discoveries about its complex pathophysiology. This study evaluated the effects of oclacitinib on pruritus scores of 20 dogs with atopic dermatitis. Levels of pruritus described by owners were diagnosed based on strict exclusion criteria, at 3 moments (days 0, 14 an 28), by quantitative and qualitative scales. In 85% of the dogs, oral administration of 0.4 - 0.6 mg/kg twice daily resulted in more than 50% reduction in pruritus level. The same dose once daily reduced pruritus in 80% of animals, being 44% the average reduction. None of them presented adverse reactions during the 28 days of evaluation. Oclacitinib has shown efficiency in the treatment of dogs with atopic dermatitis, with high rates of pruritus reduction in both dosages, especially when used every 12 hours.


2013 ◽  
Vol 24 (6) ◽  
pp. 613-e148 ◽  
Author(s):  
Tara S. Snook ◽  
Stephen D. White ◽  
Michelle G. Hawkins ◽  
Lisa A. Tell ◽  
Laura S. Wilson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document